For a successful decentralized clinical trial, you need a cross-functional team that understands the nuances of remote or hybrid studies. PharPoint’s team comes armed with experience, innovation, and processes to facilitate the flow of study information.
PharPoint has proven processes in place to successfully support DCTs. These include:
PharPoint’s team is focused on ensuring your success, keeping you ahead of study challenges and deadlines. Whether it’s through public health crises or recruitment obstacles, our team is here to support your decentralized or virtual study:
PharPoint leverages numerous industry-best technology solutions to support faster, more cost-efficient clinical research. These solutions include:
Decentralized clinical trials, or DCTs, are clinical trials where some or all trial-related activities take place at locations remote from the investigator, utilizing telemedicine, mobile/local healthcare providers, and/or mobile technologies.
Subjects visit the clinical site to complete all procedures and assessments.
Some studies may be able to be completed with minimum physical contact with a clinician.
In this approach, subject visits may be conducted using a combination of tools such as electronic Patient Reported Outcomes (ePRO) and electronic Clinician Reported Outcomes (eClinRO), with interaction via telemedicine to complete clinician-directed assessments.
Procedures usually requiring a clinic visit (e.g., vital signs, ECG, Spirometry, etc.) may be completed using wearables or peripheral devices linked to a user interface (usually an app). Subjects may have in-home visits by a clinician for specific protocol-mandated procedures, such as phlebotomy.
Studies have proven that use of virtual subject visits enhance retention rates on clinical trials.
Any combination of the different study designs.
We can leverage relationships with our strategic partners to provide a nimble response to a variety of project needs utilizing a combination of virtual and traditional approaches.